New Five-Year Data Shows Durable Efficacy Of AstraZeneca's Fasenra For Asthma TreatmentBenzinga • 05/19/21
Oxford/AstraZeneca Third Booster Strong Enough Against COVID-19 Variants, Study Shows: FTBenzinga • 05/19/21
Oxford BioMedica To Manufacture More Doses Of AstraZeneca's COVID-19 Vaccine, Upgrades 2021 OutlookBenzinga • 05/18/21
Oxford Biomedica upgrades financial guidance for supply agreement with AstraZeneca for manufacture of COVID-19 VaccineGlobeNewsWire • 05/18/21
Oxford Biomedica doubles financial guidance after AstraZeneca increases COVID-19 vaccine productionProactive Investors • 05/18/21
Mixing Pfizer and AstraZeneca Vaccines Increases Mild Side Effects but Is Safe, Study ShowsBarrons • 05/13/21
Mixing Pfizer and AstraZeneca COVID-19 vaccines increases mild side effects but is safe, study showsMarket Watch • 05/13/21
European Union Announce Second Lawsuit Against AstraZeneca Over Delayed COVID-19 Vaccine Supply: ReutersBenzinga • 05/11/21
AstraZeneca boss to receive pay hike but 40% shareholders vote against itProactive Investors • 05/11/21
Norway may drop AstraZeneca, J&J vaccines; EU will not take AstraZeneca one after JuneMarket Watch • 05/10/21
AstraZeneca faces investor backlash after hiking chief executive bonus by £2.3mlnProactive Investors • 05/10/21